The area rate of atheromatous plaque in aorta was less in specimens from both groups of AAS than in those from control I. Pathological changes in intima and media of aorta were milder in specimens from both groups of AAS.Development of pathological changes in arteries of various organs were prevented with both doses of AAS.The hypocholesterolemic effects of L-ascorbate 2-sulfate (AAS) in mice and rats have been reported in a previous paper (1) in which we suggested that AAS is a prospective hypolipidernic drug having a pronounced effect on lipid metabolism, extremely low toxicity and fewer pharmacological effects on the functions of various organs (2-4).In the present study the effects of AAS on experimental hyperlipidemia and athero sclerosis in rabbits were examined with L-ascorbate (AA) and clofibrate (CPIB) as reference compounds, and it was found that AAS possessed hypolipidemic effects in rabbits as well as in rats, and marked preventive effects on experimental atherosclerosis.
MATERIALS AND METHODS
Materials:The compounds examined for hypolipidemic effects are sodium L-ascorbate 2-sulfate-3 H2O, sodium L-ascorbate and clofibrate.Animal treatment: White male rabbits weighing approx. 2.5 kg were divided into 5 groups of nine and each animal was fed daily 100 g of laboratory chow (Nippon Clea, CR-1) supplemented with 1 of cholesterol. In addition to these 5 groups, one group of three